STEVEN GANNON
CIK 1643085 · last filed 2026-06-03
STEVEN GANNON is a corporate insider who has filed 25 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for XENE, was dated Jun 3, 2026. Across all open-market trades the lifetime net is −$372.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $618.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$618.4K
2
25
-$372.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XENE | Director | 11,870 | $52.10 | $618.4K | -$559.4K | 16 | 2026-06-03 |
| Fusion Pharmaceuticals Inc. (FUSN) Delisted | Director | 0 | $21.55 | $0 | $186.8K | 9 | 2024-06-04 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | XENE | Mixed | +1,229 | -$75.6K | EDGAR |
| 2026-05-13 | XENE | Exer (M) | +3,500 | $25.8K | EDGAR |
| 2025-06-06 | XENE | Mixed | −3 | -$91 | EDGAR |
| 2025-05-16 | XENE | Exer (M) | +5,144 | $64.7K | EDGAR |
| 2024-06-05 | XENE | Grant (A) | — | $0 | EDGAR |
| 2024-06-04 | Fusion Pharmaceuticals Inc. (FUSN) Delisted | Disp (D) | −56,400 | $0 | EDGAR |
| 2024-03-08 | XENE | Sell (S) | −13,000 | -$601.6K | EDGAR |
| 2023-06-14 | Fusion Pharmaceuticals Inc. (FUSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-02 | XENE | Grant (A) | — | $0 | EDGAR |
| 2022-08-11 | Fusion Pharmaceuticals Inc. (FUSN) Delisted | Buy (P) | +44,400 | $90.1K | EDGAR |